奇點國峯(01280.HK)擬折讓約20%配發合共1.59億股 籌資約8092萬港元
格隆匯6月28日丨奇點國峯(01280.HK)公吿,於2024年6月28日,公司分別與兩名認購人訂立兩份認購協議,據此,公司已有條件同意配發合共1.59億股股份,相當於本公吿日期現有已發行股本約20%;及經配發擴大的已發行股本約16.67%。認購價為每股股份0.512港元,較6月28日在聯交所所報的收市價每股0.64港元折讓約20%。
認購事項所得款項淨額將約為8092萬港元,公司擬將該所得款項淨額用於償還集團債務、一般運營資金及公司開支。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.